| Literature DB >> 29728950 |
Ethan Morgan1,2, Daniel T Ryan3,4, Michael E Newcomb3,4, Brian Mustanski3,4.
Abstract
Understanding pre-exposure prophylaxis (PrEP) discontinuation is key to maximizing its effectiveness at the individual and population levels. Data came from the RADAR cohort study of MSM aged 16-29 years, 2015-2017. Participants included those who reported past 6-month PrEP use and discontinued its use by the interview date. Of the 197 participants who had used PrEP in the past 6 months, 65 discontinued use. Primary reasons for PrEP discontinuation included trouble getting to doctor's appointments (14, 21.5%) and issues related to insurance coverage or loss (13, 20.0%). Few (21%) who discontinued spoke to their doctor first, which has important implications for future long acting formulations.Entities:
Keywords: Discontinuation; HIV; PrEP; YMSM
Mesh:
Substances:
Year: 2018 PMID: 29728950 PMCID: PMC6204096 DOI: 10.1007/s10461-018-2125-2
Source DB: PubMed Journal: AIDS Behav ISSN: 1090-7165